CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
INTRODUCTION: We aimed to unravel the underlying pathophysiology of the neurodegeneration (N) markers neurogranin (Ng), neurofilament light (NfL), and hippocampal volume (HCV), in Alzheimer's disease (AD) using cerebrospinal fluid (CSF) proteomics. METHODS: Individuals without dementia were cla...
Main Authors: | Delvenne, A, Gobom, J, Schindler, SE, Kate, MT, Reus, LM, Dobricic, V, Tijms, BM, Benzinger, TLS, Cruchaga, C, Teunissen, CE, Ramakers, I, Martinez‐Lage, P, Tainta, M, Vandenberghe, R, Schaeverbeke, J, Engelborghs, S, Roeck, ED, Popp, J, Peyratout, G, Tsolaki, M, Freund‐Levi, Y, Lovestone, S, Streffer, J, Barkhof, F |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley Open Access
2024
|
Similar Items
-
Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
by: Delvenne, A, et al.
Published: (2024) -
Synaptic protein CSF levels relate to memory scores in individuals without dementia
by: Wesenhagen, KEJ, et al.
Published: (2025) -
MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study
by: ten Kate, M, et al.
Published: (2018) -
Inflammatory biomarkers in Alzheimer's disease plasma
by: Morgan, A, et al.
Published: (2019) -
Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
by: Westwood, S, et al.
Published: (2020)